Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)
about
Corticosteroids as adjunctive therapy in the treatment of influenzaPolymicrobial community-acquired pneumonia: An emerging entitySupply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: summary of an ecological study.Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological studyImpact of H1N1 on socially disadvantaged populations: systematic reviewEpidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in MexicoComparison of CATs, CURB-65 and PMEWS as triage tools in pandemic influenza admissions to UK hospitals: case control analysis using retrospective dataUtility of the first few100 approach during the 2009 influenza A(H1N1) pandemic in the Netherlands.Two years after pandemic influenza A/2009/H1N1: what have we learned?Review on the impact of pregnancy and obesity on influenza virus infectionThe community impact of the 2009 influenza pandemic in the WHO European region: a comparison with historical seasonal data from 28 countries.A Role for Neutrophils in Viral Respiratory Disease.Epidemiology and outcomes of adults with asthma who were hospitalized or died with 2009 pandemic influenza A (H1N1)--California, 2009.Impact of H1N1 on socially disadvantaged populations: summary of a systematic review.Bacterial and viral infections associated with influenza.An evaluation of community assessment tools (CATs) in predicting use of clinical interventions and severe outcomes during the A(H1N1)pdm09 pandemic.The immune profile associated with acute allergic asthma accelerates clearance of influenza virusEthnic disparities in acquiring 2009 pandemic H1N1 influenza: a case-control studyComplications among adults hospitalized with influenza: a comparison of seasonal influenza and the 2009 H1N1 pandemic.Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UK.Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.Severe maternal morbidity due to respiratory disease and impact of 2009 H1N1 influenza A pandemic in Brazil: results from a national multicenter cross-sectional studyHospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality.Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine.Laboratory diagnosis, epidemiology, and clinical outcomes of pandemic influenza A and community respiratory viral infections in southern Brazil.Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults.The impact of pandemic influenza A H1N1 2009 on Australian lung transplant recipients.Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A VirusEvidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usageA prediction rule to identify severe cases among adult patients hospitalized with pandemic influenza A (H1N1) 2009.Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010Burden of hospitalizations for pandemic influenza in Slovenia.Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) diseaseClinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria.Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada.Pandemic H1N1 influenza-associated hospitalizations in children in Madrid, Spain.Risk factors for death from pandemic (H1N1) 2009, southern Brazil.Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant miceCase-based reported mortality associated with laboratory-confirmed influenza A(H1N1) 2009 virus infection in the Netherlands: the 2009-2010 pandemic season versus the 2010-2011 influenza season.Clinical characteristics and outcomes among pediatric patients hospitalized with pandemic influenza A/H1N1 2009 infection.
P2860
Q24186045-399DD95D-7FD7-43CC-8858-EA0961EEDA0AQ26780356-8443EF28-4EF5-4487-A89E-6D6E997A04D2Q27687868-F97E222B-3CE8-4D9E-973B-1C1A3C1BFDA7Q28483664-55E5C96E-D633-4C40-86BB-2455BB69EE74Q28728019-24C82890-9C40-4B4C-AA71-C5C3C3950EE1Q28729170-A0C510D1-A06D-43BA-98B5-FC42233AD1E6Q28730789-20CED3F9-FD1C-43AD-95F6-1DC59D267570Q30224045-AE817DAB-D161-4F00-A497-7E91D762CAC8Q30224656-B1D18224-7778-42BB-80EE-F667715CB4F4Q30224744-68DD9CE4-2634-4C6A-B932-F050840DCD4DQ30224750-E931F47F-787A-4397-B35F-088C30A7765DQ30234336-A9759105-F1A7-4CEA-BDEC-20A51F4F03B1Q30352055-6CAA3ACA-8B42-417F-A359-D1194F7157CCQ30353601-FCBBB971-ECB5-44F0-81FE-15C2B5252504Q30353612-7C1E6996-F01C-4951-91A1-6DC65A582B90Q30353936-66C25E7C-820B-4385-9474-94C24346CF54Q30358384-C20A960C-C840-42ED-82AF-CE8EF1AAD8BBQ30359607-F6E49E17-CD0D-45FF-AC2E-98C4A880DCF7Q30361961-F4DAC0FE-B818-43DE-AB60-785D9DBACD03Q30365369-8A45403B-6433-44F4-AC67-872625BC10BFQ30381799-B70E2129-6187-44AE-BA78-256C509DEE11Q30388374-E09E037C-4313-4E65-B985-8160802ACFCBQ30393100-2FBD2734-113B-4C7B-A1D8-6DF5E8022B6BQ30396654-7B80B615-E91A-4C9E-A8DA-4C44A8E649EAQ30398719-1EB32288-4A38-4945-81D9-8EECA2D0B76FQ30398779-1D7D8E50-EA67-4C1D-8866-A57F069E7651Q30399407-B6B34DB4-4013-4260-BAEE-CC37C1315713Q30399806-3E3EB43C-633E-49D8-9303-C06E26423E4AQ30401118-8DCED536-796E-41C2-BC2F-88A0DE2345DFQ30401555-654D20B8-B19A-4A72-B36D-949B304BD6B3Q30401581-EB61BE89-39CD-4069-AB94-E9E1A9AFB29EQ30401877-206FB3CB-73ED-4FB3-B452-E900A7D490ABQ30402302-50DC9D51-3F20-4EF8-93EF-352B787828F3Q30402352-3C657039-FCAE-47ED-946D-D109DB9DE324Q30403558-4DBE0880-1DB8-40F7-8F39-8F76CF724DB6Q30405109-5E3F9B52-BCBD-41E2-9DA7-36020EBDC500Q30405404-5C8C9A3F-B236-4F60-B33D-522C7A2224FFQ30406363-A4AFE08E-54B0-4704-8334-B460B8A6E7C6Q30407748-B6D0A6B6-08FA-4A35-9730-75A1C239AFCEQ30409532-04913B71-FF47-486B-B183-53129367DAF9
P2860
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risk factors for hospitalisati ...... irst wave (May-September 2009)
@ast
Risk factors for hospitalisati ...... irst wave (May-September 2009)
@en
Risk factors for hospitalisati ...... irst wave (May-September 2009)
@nl
type
label
Risk factors for hospitalisati ...... irst wave (May-September 2009)
@ast
Risk factors for hospitalisati ...... irst wave (May-September 2009)
@en
Risk factors for hospitalisati ...... irst wave (May-September 2009)
@nl
prefLabel
Risk factors for hospitalisati ...... irst wave (May-September 2009)
@ast
Risk factors for hospitalisati ...... irst wave (May-September 2009)
@en
Risk factors for hospitalisati ...... irst wave (May-September 2009)
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Risk factors for hospitalisati ...... irst wave (May-September 2009)
@en
P2093
B L Taylor
C Armstrong
Influenza Clinical Information Network (FLU-CIN)
J E Enstone
J McMenamin
K G Nicholson
P2860
P304
P3181
P356
10.1136/THX.2010.135210
P407
P577
2010-07-01T00:00:00Z